Preprint Review Version 2 This version is not peer-reviewed

Revisiting Prostate Cancer in India: A Genomic View

Version 1 : Received: 24 November 2018 / Approved: 26 November 2018 / Online: 26 November 2018 (05:27:07 CET)
Version 2 : Received: 2 April 2019 / Approved: 3 April 2019 / Online: 3 April 2019 (10:15:50 CEST)

How to cite: Perera, P.; Gupta, A.; Shukla, N.; Nehra, M.; Sharma, M.; Mishra, S.; Chauhan, V.S.; Vijay, M.K.; Jatawa, S.K.; Tiwari, A.; Medicherla, K.M.; Mathur, P.; Sharma, D.; Suravajhala, P. Revisiting Prostate Cancer in India: A Genomic View . Preprints 2018, 2018110571 (doi: 10.20944/preprints201811.0571.v2). Perera, P.; Gupta, A.; Shukla, N.; Nehra, M.; Sharma, M.; Mishra, S.; Chauhan, V.S.; Vijay, M.K.; Jatawa, S.K.; Tiwari, A.; Medicherla, K.M.; Mathur, P.; Sharma, D.; Suravajhala, P. Revisiting Prostate Cancer in India: A Genomic View . Preprints 2018, 2018110571 (doi: 10.20944/preprints201811.0571.v2).

Abstract

In the recent past, there has been a rise in Prostate Cancer (PCa) in Asia, particularly India.  Although systematic reviews on PCa have dealt on the genetics, genomics and the environmental influence in causal of PCa, no predictive analytics in comparing the PCa from Caucasian, American to Asian population was attempted. In this review article, we have attempted to elaborate this aspect of PCa and deliberated on challenges related to next generation sequencing methods of PCa’s manifestation when compared to the west.

Subject Areas

prostate cancer; prostate-specific antigen; incidence; genomics; next generation sequencing

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our diversity statement.

Leave a public comment
Send a private comment to the author(s)
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.